These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

523 related articles for article (PubMed ID: 30509990)

  • 1. Synergistic neuroprotection by coffee components eicosanoyl-5-hydroxytryptamide and caffeine in models of Parkinson's disease and DLB.
    Yan R; Zhang J; Park HJ; Park ES; Oh S; Zheng H; Junn E; Voronkov M; Stock JB; Mouradian MM
    Proc Natl Acad Sci U S A; 2018 Dec; 115(51):E12053-E12062. PubMed ID: 30509990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lewy-like aggregation of α-synuclein reduces protein phosphatase 2A activity in vitro and in vivo.
    Wu J; Lou H; Alerte TN; Stachowski EK; Chen J; Singleton AB; Hamilton RL; Perez RG
    Neuroscience; 2012 Apr; 207():288-97. PubMed ID: 22326202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced phosphatase activity attenuates α-synucleinopathy in a mouse model.
    Lee KW; Chen W; Junn E; Im JY; Grosso H; Sonsalla PK; Feng X; Ray N; Fernandez JR; Chao Y; Masliah E; Voronkov M; Braithwaite SP; Stock JB; Mouradian MM
    J Neurosci; 2011 May; 31(19):6963-71. PubMed ID: 21562258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotective and anti-inflammatory properties of a coffee component in the MPTP model of Parkinson's disease.
    Lee KW; Im JY; Woo JM; Grosso H; Kim YS; Cristovao AC; Sonsalla PK; Schuster DS; Jalbut MM; Fernandez JR; Voronkov M; Junn E; Braithwaite SP; Stock JB; Mouradian MM
    Neurotherapeutics; 2013 Jan; 10(1):143-53. PubMed ID: 23296837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calpain-cleavage of alpha-synuclein: connecting proteolytic processing to disease-linked aggregation.
    Dufty BM; Warner LR; Hou ST; Jiang SX; Gomez-Isla T; Leenhouts KM; Oxford JT; Feany MB; Masliah E; Rohn TT
    Am J Pathol; 2007 May; 170(5):1725-38. PubMed ID: 17456777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear and neuritic distribution of serine-129 phosphorylated alpha-synuclein in transgenic mice.
    Schell H; Hasegawa T; Neumann M; Kahle PJ
    Neuroscience; 2009 Jun; 160(4):796-804. PubMed ID: 19272424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 14-3-3 Proteins Reduce Cell-to-Cell Transfer and Propagation of Pathogenic α-Synuclein.
    Wang B; Underwood R; Kamath A; Britain C; McFerrin MB; McLean PJ; Volpicelli-Daley LA; Whitaker RH; Placzek WJ; Becker K; Ma J; Yacoubian TA
    J Neurosci; 2018 Sep; 38(38):8211-8232. PubMed ID: 30093536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of amyloidogenic proteins in pancreatic β cells from subjects with synucleinopathies.
    Martinez-Valbuena I; Amat-Villegas I; Valenti-Azcarate R; Carmona-Abellan MDM; Marcilla I; Tuñon MT; Luquin MR
    Acta Neuropathol; 2018 Jun; 135(6):877-886. PubMed ID: 29536165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations in mGluR5 expression and signaling in Lewy body disease and in transgenic models of alpha-synucleinopathy--implications for excitotoxicity.
    Price DL; Rockenstein E; Ubhi K; Phung V; MacLean-Lewis N; Askay D; Cartier A; Spencer B; Patrick C; Desplats P; Ellisman MH; Masliah E
    PLoS One; 2010 Nov; 5(11):e14020. PubMed ID: 21103359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic benefits of a component of coffee in a rat model of Alzheimer's disease.
    Basurto-Islas G; Blanchard J; Tung YC; Fernandez JR; Voronkov M; Stock M; Zhang S; Stock JB; Iqbal K
    Neurobiol Aging; 2014 Dec; 35(12):2701-2712. PubMed ID: 25034344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lovastatin ameliorates alpha-synuclein accumulation and oxidation in transgenic mouse models of alpha-synucleinopathies.
    Koob AO; Ubhi K; Paulsson JF; Kelly J; Rockenstein E; Mante M; Adame A; Masliah E
    Exp Neurol; 2010 Feb; 221(2):267-74. PubMed ID: 19944097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The novel mechanism of rotenone-induced α-synuclein phosphorylation via reduced protein phosphatase 2A activity.
    Wang Y; Liu J; Chen M; Du T; Duan C; Gao G; Yang H
    Int J Biochem Cell Biol; 2016 Jun; 75():34-44. PubMed ID: 27012437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective molecular alterations in the autophagy pathway in patients with Lewy body disease and in models of alpha-synucleinopathy.
    Crews L; Spencer B; Desplats P; Patrick C; Paulino A; Rockenstein E; Hansen L; Adame A; Galasko D; Masliah E
    PLoS One; 2010 Feb; 5(2):e9313. PubMed ID: 20174468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NK cells clear α-synuclein and the depletion of NK cells exacerbates synuclein pathology in a mouse model of α-synucleinopathy.
    Earls RH; Menees KB; Chung J; Gutekunst CA; Lee HJ; Hazim MG; Rada B; Wood LB; Lee JK
    Proc Natl Acad Sci U S A; 2020 Jan; 117(3):1762-1771. PubMed ID: 31900358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroinflammation is associated with infiltration of T cells in Lewy body disease and α-synuclein transgenic models.
    Iba M; Kim C; Sallin M; Kwon S; Verma A; Overk C; Rissman RA; Sen R; Sen JM; Masliah E
    J Neuroinflammation; 2020 Jul; 17(1):214. PubMed ID: 32680537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased oligomerization and phosphorylation of α-synuclein are associated with decreased activity of glucocerebrosidase and protein phosphatase 2A in aging monkey brains.
    Liu G; Chen M; Mi N; Yang W; Li X; Wang P; Yin N; Li Y; Yue F; Chan P; Yu S
    Neurobiol Aging; 2015 Sep; 36(9):2649-59. PubMed ID: 26149921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential insular cortex subregional vulnerability to α-synuclein pathology in Parkinson's disease and dementia with Lewy bodies.
    Fathy YY; Jonker AJ; Oudejans E; de Jong FJJ; van Dam AW; Rozemuller AJM; van de Berg WDJ
    Neuropathol Appl Neurobiol; 2019 Apr; 45(3):262-277. PubMed ID: 29797340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha-synuclein overexpression increases phospho-protein phosphatase 2A levels via formation of calmodulin/Src complex.
    Yang W; Wang X; Duan C; Lu L; Yang H
    Neurochem Int; 2013 Sep; 63(3):180-94. PubMed ID: 23796501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunotherapy targeting toll-like receptor 2 alleviates neurodegeneration in models of synucleinopathy by modulating α-synuclein transmission and neuroinflammation.
    Kim C; Spencer B; Rockenstein E; Yamakado H; Mante M; Adame A; Fields JA; Masliah D; Iba M; Lee HJ; Rissman RA; Lee SJ; Masliah E
    Mol Neurodegener; 2018 Aug; 13(1):43. PubMed ID: 30092810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transgenic mice overexpressing tyrosine-to-cysteine mutant human alpha-synuclein: a progressive neurodegenerative model of diffuse Lewy body disease.
    Zhou W; Milder JB; Freed CR
    J Biol Chem; 2008 Apr; 283(15):9863-70. PubMed ID: 18238775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.